Nataliya Bondareva

Mrs. Nataliya Bondareva


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2022 in The Journal of Antibiotics
Verified
Journal Article
Closed access
PDF file
NBNataliya Bondareva
Nataliya Bondareva
ASAnna V. Soloveva
Anna V. Soloveva
ASAnna Sheremet
Anna Sheremet
EKEkaterina A. Koroleva
Ekaterina A. Koroleva
LKLidiya N. Kapotina
Lidiya N. Kapotina
NZNailya A. Zigangirova
Nailya A. Zigangirova

15 March 2023 in The Journal of Antibiotics
Verified
Journal Article
Closed access
PDF file
EKEkaterina Koroleva
Ekaterina Koroleva
ASA. V. Soloveva
A. V. Soloveva
EME. Y. Morgunova
E. Y. Morgunova
LKL. N. Kapotina
L. N. Kapotina
SLS. V. Luyksaar
S. V. Luyksaar
AGA. L. Gintsburg
A. L. Gintsburg

21 April 2023 in The Journal of Antibiotics
Verified
Journal Article
Closed access
PDF file
STS. V. Tsarenko
S. V. Tsarenko
NZNailya Zigangirova
Nailya Zigangirova
ASA. V. Soloveva
A. V. Soloveva
NBNataliya Bondareva
Nataliya Bondareva
EKE. A. Koroleva
E. A. Koroleva
AGA. L. Gintsburg
A. L. Gintsburg

Verified
Journal Article
Open access
PDF file
NBNataliya Bondareva
Nataliya Bondareva
ASAnna Sheremet
Anna Sheremet
EMElena Y. Morgunova
Elena Y. Morgunova
IKIrina R. Khisaeva
Irina R. Khisaeva
APAlisa Parfenova
Alisa Parfenova
Ludmila BoinovichLudmila Boinovich
Ludmila Boinovich
The global spread of multidrug-resistant (MDR) hospital-acquired pathogens is a serious problem for healthcare units. The challenge of the spreading of nosocomial infections, also known as hospital-acquired pathogens, including Pseudomonas aeruginosa, must be addressed not only by developing effective drugs, but also by improving preventive measures in hospitals, such as passive bactericidal coatings deposited onto the touch surfaces. In this paper, we studied the antibacterial activity of superhydrophilic and superhydrophobic copper surfaces against the P. aeruginosa strain PA103 and its four different polyresistant clinical isolates with MDR. To fabricate superhydrophilic and superhydrophobic coatings, we subjected the copper surfaces to laser processing with further chemosorption of fluorooxysilane to get a superhydrophobic substrate. The antibacterial activity of superhydrophilic and superhydrophobic copper surfaces was shown, with respect to both the collection strain PA103 and polyresistant clinical isolates of P. aeruginosa, and the evolution of the decontamination of a bacterial suspension is presented and discussed. The presented results indicate the promising potential of the exploitation of superhydrophilic coatings in the manufacture of contact surfaces for healthcare units, where the risk of infection spread and contamination by hospital-acquired pathogens is extremely high.

11 August 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
ASAleksei Slonov
Aleksei Slonov
MAMariam Abdulkadieva
Mariam Abdulkadieva
EKEgor Kalinin
Egor Kalinin
NBNataliya Bondareva
Nataliya Bondareva
LKLydia Kapotina
Lydia Kapotina
AGAlexander Gintsburg
Alexander Gintsburg
Background/Objectives: Fluorothiazinone (FT), a small molecule of the 2,4-disubstituted-4H-[1,3,4]-thiadiazine-5-one class, is known to inhibit the type III secretion system (T3SS) in Gram-negative bacteria and has shown therapeutic potential in animal models and clinical trials. Given the evolutionary relationship between the T3SS and the bacterial flagellar apparatus, this study aimed to investigate the effects of FT on bacterial motility and flagellum assembly. Methods: Motility was assessed in Pseudomonas aeruginosa, Proteus mirabilis, pathogenic Escherichia coli, and Listeria monocytogenes using a semisolid agar assay and a microfluidic motility system. The mechanism of FT’s action was further examined through time-course analysis, Western blotting of surface flagella proteins, and transmission electron microscopy (TEM). Results: FT inhibited motility of P. aeruginosa, P. mirabilis, and E. coli in a dose-dependent manner, while L. monocytogenes motility remained unaffected. The inhibitory effect was not immediate but delayed 2–3 h post FT addition. Western blotting revealed the absence of surface flagella in EHEC grown with FT, and TEM confirmed structural disruption of flagella in P. mirabilis. Conclusions: FT selectively inhibits flagellum-based motility in Gram-negative bacteria. Obtained data suggested FT interference with flagellum biosynthesis rather than disruption of rotation. Motility inhibition can contribute to FT therapeutic effects on Gram-negative bacterial infections.

15 March 2024 in The Journal of Antibiotics
Verified
Journal Article
Closed access
PDF file
MSMark V. Savitskii
Mark V. Savitskii
NMNatalia Moskaleva
Natalia Moskaleva
ABAlex Brito
Alex Brito
PMPavel A. Markin
Pavel A. Markin
NZNailya A. Zigangirova
Nailya A. Zigangirova
SASvetlana A. Appolonova
Svetlana A. Appolonova